Professional Documents
Culture Documents
2
Infective
Non-
STI STI
Non-infective
Vaginal Discharge
3
Trends in Endocrinology & Metabolism, July 2016, Vol. 27, No. 7
4
Vaginal Infectious Disease in
Different Flora Types
Best Practice & Research Clinical Obstetrics and Gynaecology Vol. 21,
No. 3, pp. 355–373, 2007 5
Vaginal Infection
70%
6
7
8
Metronidazol
e Tinidazole
Clindamycin
Azole
(clotrimazole,
miconazole,
fluconazole,
itraconazole)
Doxycycline
Azithromycin
Erythromycin
Ceftriaxone
9
Cefixime
Ciprofloxacin
Ofloxacin
10
(Algorithms for Obstetrics and Gynaecology, 2014)
11
• Local vs systemic route
• Significant proportion of
patients do not achieve an
adequate response
• Recurrence of BV/ VVC
frequently occurs
• Drug resistance may
•develop
Risk of post-treatment
candidiasis How to improve?
12
Anaerobic gram-negative rod resistant
13
14
15
16
10 mg Estimated 2.5 to 5 ml
of vaginal fluid
vagina (4000-2000 mg/l)
l
17
In vitro antimicrobial activity of DQC
Arch Gynecol Obstet (2016) 293:14869–484
MIC of a. vaginae (different strains) for
DQC, clindamycin and metronidazole
19
Dequalinium chloride 10 mg Povidone iodine 200 mg
20
DQC
DQC DQC
22
Local tolerance (ADRs 2,4-7,8%)
Pregnant women (No ADRs, 1st
trimester use)
Minimal vaginal absorption
23
From a clinical point of view DQC could
offer an attractive treatment for vaginal
infections, both for BV and VVC as well as
in case of mixed infections
Thank you
24